Skip to main content
SKYA
NASDAQ Crypto Assets

SkyAI Posts $109.5M H1 Loss as Solana Holdings Tumble; Pivots to AI Finance Platform

Arie Shkolnikov · Analysis by Wiseek AI
Sentiment info
Negative
Importance info
8
Price
$1.16
Mkt Cap
$49.094M
52W Low
$0.91
52W High
$18.23
52W Position info
27% above low
Off High info
94% below high
Rel. Volume
Market data snapshot near publication time

SKYA sits 27% above its 52-week low of $0.91.

Summary

SkyAI reported a $109.5M net loss for H1 2026 as its Solana treasury lost nearly half its value. The company is pivoting to an AI finance platform while defending against takeovers with a new poison pill.


Key Events · Earnings and Guidance · SKYA

  • Massive Loss on Digital Assets

    H1 2026 net loss of $109.5M includes $84.3M unrealized and $14.7M realized losses on Solana holdings. The digital commodity portfolio fell from $250.1M to $144.3M.

  • Strategic Pivot to AI Finance

    Company announced a shift to building an agentic finance platform for emerging markets, with a new Hong Kong headquarters. Legacy medical device operations are now discontinued.

  • Poison Pill Adopted

    Board adopted a limited-duration stockholder rights plan on May 13, 2026, triggered if any person acquires 15% or more of the company without board approval. This follows the July 17 rejection of an unsolicited takeover bid.

  • Share Buybacks Continue

    Repurchased 1,213,669 shares for $2.0M during H1 2026 under the $100M buyback program. $98M remains authorized.


Analysis · SKYA · Crypto Assets

SkyAI's pivot from medical devices to a crypto treasury strategy has backfired dramatically. The company reported a $109.5 million net loss for the first half of 2026, driven by $99 million in combined realized and unrealized losses on its Solana holdings as the token's price plunged. The digital commodity portfolio, once valued at $250 million, has shrunk to $144 million. Against this backdrop, management is attempting another transformation — this time into an AI-powered finance platform targeting emerging markets. The company has established a Hong Kong base and adopted a poison pill, likely in response to the recently rejected unsolicited takeover bid. With only $12 million in cash and a $100 million buyback program largely unused, the runway depends on Solana's recovery or further asset sales at depressed prices.

How filings like this one have moved

In the 30 days to Oct 26, 2026, 36.2% of the 898 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.75%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SKYA was trading at $1.16 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $49.1M. The 52-week trading range was $0.91 to $18.23. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SKYA - Latest Insights

SKYA
Oct 21, 2026, 9:00 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $2.82
Real-time Price: $2.86 info
Change: +$0.0367 (+1%) info
Market Cap: $146.969M info
SKYA
Oct 19, 2026, 6:00 PM EDT
Source: CryptoProwl
Importance Score:
7
Price at Filing: $2.77
Real-time Price: $2.86 info
Change: +$0.0879 (+3%) info
Market Cap: $146.969M info
SKYA
Oct 19, 2026, 5:04 PM EDT
Source: Cointelegraph
Importance Score:
7
Price at Filing: $2.78
Real-time Price: $2.86 info
Change: +$0.080 (+3%) info
Market Cap: $146.969M info
SKYA
Oct 19, 2026, 10:29 AM EDT
Source: Bloomingbit
Importance Score:
7
Price at Filing: $2.81
Real-time Price: $2.86 info
Change: +$0.055 (+2%) info
Market Cap: $146.969M info
SKYA
Oct 19, 2026, 9:14 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.74
Real-time Price: $2.86 info
Change: +$0.120 (+4%) info
Market Cap: $146.969M info